| Ms Djana Harp, MD | |
|
510 Clinton Ave, Bridgeport, CT 06605-1701 | |
| (203) 330-6000 | |
| (203) 382-2954 |
| Full Name | Ms Djana Harp |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 23 Years |
| Location | 510 Clinton Ave, Bridgeport, Connecticut |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063402584 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 056457 (Georgia) | Secondary |
| 207V00000X | Obstetrics & Gynecology | 55781 (Connecticut) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Norwalk Community Health Center Inc | 6305988510 | 24 |
News Archive
A Phase 1 clinical trial testing the safety and effectiveness of a monoclonal antibody (mAb) against malaria has begun enrolling healthy adult volunteers at the National Institutes of Health Clinical Center in Bethesda, Maryland. The trial, sponsored by NIH's National Institute of Allergy and Infectious Diseases (NIAID), is the first to test mAb CIS43LS in humans. It aims to enroll up to 73 volunteers aged 18 through 50 years old who have never had malaria.
Pro-Pharmaceuticals, Inc., a developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today reported its financial results for the third quarter and the nine months ended September 30, 2010. These results are included in the Company's Quarterly Report on Form 10-Q, which has been filed with the SEC.
Angiotech Pharmaceuticals, Inc. today announced Cook Medical, a license holder of Angiotech's paclitaxel technology, has enrolled the first patient in its landmark Formula PTX clinical trial. The trial is the first of its kind to evaluate the safety and effectiveness of a paclitaxel-eluting stent to treat renal artery disease, the narrowing of the arteries that supply blood to the kidneys.
Lennart Mucke, MD, who directs neurological research at the Gladstone Institutes, has received the Khalid Iqbal Lifetime Achievement Award for his exceptional contributions to Alzheimer's disease research. The Alzheimer's Association presented the award to Dr. Mucke today at the 2012 Alzheimer's Association International Conference (AAIC) in Vancouver, Canada.
The David Geffen School of Medicine at UCLA and the UCLA Henry Samueli School of Engineering and Applied Science have formed a new center whose mission is to improve the quality and reliability of new health care technologies, reduce the length and cost of hospital stays, and allow more patients to heal in their own homes.
› Verified 9 days ago
| Entity Name | Physicians For Women's Health, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801826680 PECOS PAC ID: 3274430665 Enrollment ID: O20031215000455 |
News Archive
A Phase 1 clinical trial testing the safety and effectiveness of a monoclonal antibody (mAb) against malaria has begun enrolling healthy adult volunteers at the National Institutes of Health Clinical Center in Bethesda, Maryland. The trial, sponsored by NIH's National Institute of Allergy and Infectious Diseases (NIAID), is the first to test mAb CIS43LS in humans. It aims to enroll up to 73 volunteers aged 18 through 50 years old who have never had malaria.
Pro-Pharmaceuticals, Inc., a developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today reported its financial results for the third quarter and the nine months ended September 30, 2010. These results are included in the Company's Quarterly Report on Form 10-Q, which has been filed with the SEC.
Angiotech Pharmaceuticals, Inc. today announced Cook Medical, a license holder of Angiotech's paclitaxel technology, has enrolled the first patient in its landmark Formula PTX clinical trial. The trial is the first of its kind to evaluate the safety and effectiveness of a paclitaxel-eluting stent to treat renal artery disease, the narrowing of the arteries that supply blood to the kidneys.
Lennart Mucke, MD, who directs neurological research at the Gladstone Institutes, has received the Khalid Iqbal Lifetime Achievement Award for his exceptional contributions to Alzheimer's disease research. The Alzheimer's Association presented the award to Dr. Mucke today at the 2012 Alzheimer's Association International Conference (AAIC) in Vancouver, Canada.
The David Geffen School of Medicine at UCLA and the UCLA Henry Samueli School of Engineering and Applied Science have formed a new center whose mission is to improve the quality and reliability of new health care technologies, reduce the length and cost of hospital stays, and allow more patients to heal in their own homes.
› Verified 9 days ago
| Entity Name | South-west Community Health Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699703686 PECOS PAC ID: 2466445200 Enrollment ID: O20040420001098 |
News Archive
A Phase 1 clinical trial testing the safety and effectiveness of a monoclonal antibody (mAb) against malaria has begun enrolling healthy adult volunteers at the National Institutes of Health Clinical Center in Bethesda, Maryland. The trial, sponsored by NIH's National Institute of Allergy and Infectious Diseases (NIAID), is the first to test mAb CIS43LS in humans. It aims to enroll up to 73 volunteers aged 18 through 50 years old who have never had malaria.
Pro-Pharmaceuticals, Inc., a developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today reported its financial results for the third quarter and the nine months ended September 30, 2010. These results are included in the Company's Quarterly Report on Form 10-Q, which has been filed with the SEC.
Angiotech Pharmaceuticals, Inc. today announced Cook Medical, a license holder of Angiotech's paclitaxel technology, has enrolled the first patient in its landmark Formula PTX clinical trial. The trial is the first of its kind to evaluate the safety and effectiveness of a paclitaxel-eluting stent to treat renal artery disease, the narrowing of the arteries that supply blood to the kidneys.
Lennart Mucke, MD, who directs neurological research at the Gladstone Institutes, has received the Khalid Iqbal Lifetime Achievement Award for his exceptional contributions to Alzheimer's disease research. The Alzheimer's Association presented the award to Dr. Mucke today at the 2012 Alzheimer's Association International Conference (AAIC) in Vancouver, Canada.
The David Geffen School of Medicine at UCLA and the UCLA Henry Samueli School of Engineering and Applied Science have formed a new center whose mission is to improve the quality and reliability of new health care technologies, reduce the length and cost of hospital stays, and allow more patients to heal in their own homes.
› Verified 9 days ago
| Entity Name | Norwalk Community Health Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841226347 PECOS PAC ID: 6305988510 Enrollment ID: O20130614000037 |
News Archive
A Phase 1 clinical trial testing the safety and effectiveness of a monoclonal antibody (mAb) against malaria has begun enrolling healthy adult volunteers at the National Institutes of Health Clinical Center in Bethesda, Maryland. The trial, sponsored by NIH's National Institute of Allergy and Infectious Diseases (NIAID), is the first to test mAb CIS43LS in humans. It aims to enroll up to 73 volunteers aged 18 through 50 years old who have never had malaria.
Pro-Pharmaceuticals, Inc., a developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today reported its financial results for the third quarter and the nine months ended September 30, 2010. These results are included in the Company's Quarterly Report on Form 10-Q, which has been filed with the SEC.
Angiotech Pharmaceuticals, Inc. today announced Cook Medical, a license holder of Angiotech's paclitaxel technology, has enrolled the first patient in its landmark Formula PTX clinical trial. The trial is the first of its kind to evaluate the safety and effectiveness of a paclitaxel-eluting stent to treat renal artery disease, the narrowing of the arteries that supply blood to the kidneys.
Lennart Mucke, MD, who directs neurological research at the Gladstone Institutes, has received the Khalid Iqbal Lifetime Achievement Award for his exceptional contributions to Alzheimer's disease research. The Alzheimer's Association presented the award to Dr. Mucke today at the 2012 Alzheimer's Association International Conference (AAIC) in Vancouver, Canada.
The David Geffen School of Medicine at UCLA and the UCLA Henry Samueli School of Engineering and Applied Science have formed a new center whose mission is to improve the quality and reliability of new health care technologies, reduce the length and cost of hospital stays, and allow more patients to heal in their own homes.
› Verified 9 days ago
| Entity Name | Prospect Ct Medical Foundation Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144677568 PECOS PAC ID: 7416244496 Enrollment ID: O20160919001322 |
News Archive
A Phase 1 clinical trial testing the safety and effectiveness of a monoclonal antibody (mAb) against malaria has begun enrolling healthy adult volunteers at the National Institutes of Health Clinical Center in Bethesda, Maryland. The trial, sponsored by NIH's National Institute of Allergy and Infectious Diseases (NIAID), is the first to test mAb CIS43LS in humans. It aims to enroll up to 73 volunteers aged 18 through 50 years old who have never had malaria.
Pro-Pharmaceuticals, Inc., a developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today reported its financial results for the third quarter and the nine months ended September 30, 2010. These results are included in the Company's Quarterly Report on Form 10-Q, which has been filed with the SEC.
Angiotech Pharmaceuticals, Inc. today announced Cook Medical, a license holder of Angiotech's paclitaxel technology, has enrolled the first patient in its landmark Formula PTX clinical trial. The trial is the first of its kind to evaluate the safety and effectiveness of a paclitaxel-eluting stent to treat renal artery disease, the narrowing of the arteries that supply blood to the kidneys.
Lennart Mucke, MD, who directs neurological research at the Gladstone Institutes, has received the Khalid Iqbal Lifetime Achievement Award for his exceptional contributions to Alzheimer's disease research. The Alzheimer's Association presented the award to Dr. Mucke today at the 2012 Alzheimer's Association International Conference (AAIC) in Vancouver, Canada.
The David Geffen School of Medicine at UCLA and the UCLA Henry Samueli School of Engineering and Applied Science have formed a new center whose mission is to improve the quality and reliability of new health care technologies, reduce the length and cost of hospital stays, and allow more patients to heal in their own homes.
› Verified 9 days ago
| Entity Name | Obhg Connecticut Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861985129 PECOS PAC ID: 5890164792 Enrollment ID: O20221216000249 |
News Archive
A Phase 1 clinical trial testing the safety and effectiveness of a monoclonal antibody (mAb) against malaria has begun enrolling healthy adult volunteers at the National Institutes of Health Clinical Center in Bethesda, Maryland. The trial, sponsored by NIH's National Institute of Allergy and Infectious Diseases (NIAID), is the first to test mAb CIS43LS in humans. It aims to enroll up to 73 volunteers aged 18 through 50 years old who have never had malaria.
Pro-Pharmaceuticals, Inc., a developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today reported its financial results for the third quarter and the nine months ended September 30, 2010. These results are included in the Company's Quarterly Report on Form 10-Q, which has been filed with the SEC.
Angiotech Pharmaceuticals, Inc. today announced Cook Medical, a license holder of Angiotech's paclitaxel technology, has enrolled the first patient in its landmark Formula PTX clinical trial. The trial is the first of its kind to evaluate the safety and effectiveness of a paclitaxel-eluting stent to treat renal artery disease, the narrowing of the arteries that supply blood to the kidneys.
Lennart Mucke, MD, who directs neurological research at the Gladstone Institutes, has received the Khalid Iqbal Lifetime Achievement Award for his exceptional contributions to Alzheimer's disease research. The Alzheimer's Association presented the award to Dr. Mucke today at the 2012 Alzheimer's Association International Conference (AAIC) in Vancouver, Canada.
The David Geffen School of Medicine at UCLA and the UCLA Henry Samueli School of Engineering and Applied Science have formed a new center whose mission is to improve the quality and reliability of new health care technologies, reduce the length and cost of hospital stays, and allow more patients to heal in their own homes.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Djana Harp, MD 46 Albion St, Bridgeport, CT 06605-2602 Ph: (203) 330-6000 | Ms Djana Harp, MD 510 Clinton Ave, Bridgeport, CT 06605-1701 Ph: (203) 330-6000 |
News Archive
A Phase 1 clinical trial testing the safety and effectiveness of a monoclonal antibody (mAb) against malaria has begun enrolling healthy adult volunteers at the National Institutes of Health Clinical Center in Bethesda, Maryland. The trial, sponsored by NIH's National Institute of Allergy and Infectious Diseases (NIAID), is the first to test mAb CIS43LS in humans. It aims to enroll up to 73 volunteers aged 18 through 50 years old who have never had malaria.
Pro-Pharmaceuticals, Inc., a developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today reported its financial results for the third quarter and the nine months ended September 30, 2010. These results are included in the Company's Quarterly Report on Form 10-Q, which has been filed with the SEC.
Angiotech Pharmaceuticals, Inc. today announced Cook Medical, a license holder of Angiotech's paclitaxel technology, has enrolled the first patient in its landmark Formula PTX clinical trial. The trial is the first of its kind to evaluate the safety and effectiveness of a paclitaxel-eluting stent to treat renal artery disease, the narrowing of the arteries that supply blood to the kidneys.
Lennart Mucke, MD, who directs neurological research at the Gladstone Institutes, has received the Khalid Iqbal Lifetime Achievement Award for his exceptional contributions to Alzheimer's disease research. The Alzheimer's Association presented the award to Dr. Mucke today at the 2012 Alzheimer's Association International Conference (AAIC) in Vancouver, Canada.
The David Geffen School of Medicine at UCLA and the UCLA Henry Samueli School of Engineering and Applied Science have formed a new center whose mission is to improve the quality and reliability of new health care technologies, reduce the length and cost of hospital stays, and allow more patients to heal in their own homes.
› Verified 9 days ago
Dr. Joanne Lynn Wible-kant, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 4749 Main St, Bridgeport, CT 06606 Phone: 203-365-4922 Fax: 203-374-2377 | |
Stephen Francis Thung, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 267 Grant St Dept 8th, Bridgeport, CT 06610 Phone: 203-384-4048 | |
Matthew Chike Nwosu, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 982 E Main St, Bridgeport, CT 06608 Phone: 203-696-3260 Fax: 203-696-3269 | |
Dr. Stevan Marjanovic, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3180 Main St, Suite 202, Bridgeport, CT 06606 Phone: 203-374-0404 | |
Sarah Kate Leite, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3180 Main St, Bridgeport, CT 06606 Phone: 203-374-0404 Fax: 203-372-4167 | |
Dr. Lindsay Lauren Goodman, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 267 Grant St, Bridgeport, CT 06610 Phone: 203-384-3000 |